Author

Roland Thünauer

Leibniz Institute of Virology (LIV)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Biruhalem TayeiD· 1 shared Caroline BarischiD· 1 shared Dominik SchwudkeiD· 1 shared Hendrik Koliwer‐BrandliD· 1 shared Hubert HilbiiD· 1 shared Jan KosińskiiD· 1 shared Leonhard F. BreitsprecheriD· 1 shared Lyudmil RaykoviD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Biruhalem TayeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intracellular compartmentalization shapes lipid access and metabolic fitness of mycobacteria

Mélanie Foulon, Sylvana V. Hüttel, Leonhard F. Breitsprecher, Wiebke Gauda, Lyudmil Raykov, Hendrik Koliwer‐Brandl, Miriam Ohlhagen, Roland Thünauer, Dominik Schwudke, Hubert Hilbi, Thierry Soldati, Caroline Barisch

The paper shows that lipid metabolism in mycobacteria is linked to their subcellular location, with FACL6 deletion disrupting lipid handling and reducing intracellular fitness.

bioRxiv · Feb 11, 2026 · PreprintCell Biology

Identifying repurposed drugs with moderate anti-influenza virus activity through computational prioritization of drug-target pairs

Biruhalem Taye, Roland Thünauer, Richard Joseph Sugrue, Sebastian Maurer‐Stroh, Jan Kosiński

This study identifies potential antiviral drugs against influenza virus by computationally prioritizing drug-target pairs and validating their activity in cell lines.

bioRxiv · Jul 31, 2023 · PreprintSystems Biology